Break-induced replication and genome rearrangements

断裂诱导的复制和基因组重排

基本信息

项目摘要

DESCRIPTION (provided by applicant): DNA double strand breaks (DSBs) are cytotoxic lesions that occur spontaneously during normal cell metabolism or by treatment of cells with DNA-damaging agents. If unrepaired or repaired inappropriately, DSBs can lead to mutagenic events, such as chromosome loss, deletions, duplications or translocations, events that can lead to carcinogenesis. The homology-dependent repair of DSBs usually occurs by a conservative gene conversion mechanism, preventing extensive loss of heterozygosity (LOH) or chromosome rearrangements. Breaks that present only one end for repair, for example at eroded uncapped telomeres or when homology is limited to one side of the DSB, are thought to repair by strand invasion into a homologous duplex DNA followed by replication to the chromosome end (break-induced replication, BIR). As BIR from one of the two ends of a DSB would result in extensive LOH it suggests BIR is suppressed when DSBs have two ends in order for repair to occur by a more conservative HR mechanism. Furthermore, our studies have shown that the replication intermediate formed during BIR is unstable and the invading end can switch to a different template resulting in a translocation. BIR and a related mechanism, fork stalling and template switching (FoSTeS), are thought to be responsible for many of the genome rearrangements that give rise to non-reciprocal translocations and copy number variation associated with human disease. The goals of this proposal are to understand the mechanisms of BIR and how cells switch from gene conversion to the BIR mode of repair. The specific aims are: (1) To use a new genetic assay that detects template switching to identify the genes that regulate this process. (2) To determine whether there is a bias in the use of ectopic templates for non-reciprocal translocations that arise during BIR. (3) Physical methods will be used to determine whether DNA synthesis associated with BIR is conservative or non-conservative, the rate of fork movement will be determined by DNA combing, and the role of different DNA polymerases and the Mcm2-7 replicative helicase in the initiation and completion of BIR will be determined. PUBLIC HEALTH RELEVANCE: The repair of DNA double-strand breaks by break-induced replication (BIR) can lead to several types of chromosome rearrangements that are associated with human disease. BIR is also involved in maintaining telomere length in the absence of telomerase and this process is activated in some human tumors. In this proposal, genetic and physical approaches will be used to identify the genes that regulate chromosome rearrangements during BIR, and to define the mechanism for DNA synthesis used in BIR.
描述(由申请人提供): DNA双链断裂(DSB)是细胞毒性损伤,在正常细胞代谢过程中自发发生或通过用DNA损伤剂处理细胞而发生。如果未修复或修复不当,DSB可能导致诱变事件,如染色体丢失、缺失、复制或易位,这些事件可能导致致癌作用。DSB的同源依赖性修复通常通过保守的基因转换机制发生,防止广泛杂合性丢失(洛)或染色体重排。仅呈现一个末端用于修复的断裂,例如在侵蚀的未加帽的端粒处或当同源性限于DSB的一侧时,被认为通过链侵入同源双链体DNA中,随后复制到染色体末端(断裂诱导的复制,BIR)来修复。由于来自DSB两端之一的BIR将导致广泛的洛缺失,这表明当DSB具有两端时,BIR被抑制,以便通过更保守的HR机制进行修复。此外,我们的研究表明,在BIR过程中形成的复制中间体是不稳定的,入侵端可以切换到不同的模板,导致易位。BIR和相关的机制,叉停滞和模板转换(FoSTeS),被认为是负责许多基因组重排,引起非相互易位和拷贝数变异与人类疾病。该提案的目标是了解BIR的机制以及细胞如何从基因转换转换到BIR修复模式。具体目标是:(1)使用一种新的检测模板转换的基因检测方法来鉴定调控这一过程的基因。(2)确定在BIR期间出现的非相互易位中使用异位模板是否存在偏倚。(3)将使用物理方法来确定与BIR相关的DNA合成是保守的还是非保守的,叉运动的速率将通过DNA梳理来确定,并确定不同DNA聚合酶和Mcm 2 -7复制解旋酶在BIR的启动和完成中的作用。 公共卫生关系: 断裂诱导复制(BIR)修复DNA双链断裂可导致与人类疾病相关的几种类型的染色体重排。BIR还参与在端粒酶不存在的情况下维持端粒长度,并且该过程在一些人类肿瘤中被激活。在这个建议中,遗传和物理的方法将被用来确定在BIR过程中调节染色体重排的基因,并定义在BIR中使用的DNA合成的机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Lorraine S Symington其他文献

Lorraine S Symington的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Lorraine S Symington', 18)}}的其他基金

Genome and Epigenome Integrity In Cancer
癌症中的基因组和表观基因组完整性
  • 批准号:
    10667628
  • 财政年份:
    2022
  • 资助金额:
    $ 30.04万
  • 项目类别:
Rad52-dependent recombination in response to replication stress
响应复制压力的 Rad52 依赖性重组
  • 批准号:
    9894801
  • 财政年份:
    2019
  • 资助金额:
    $ 30.04万
  • 项目类别:
Mechanism and regulation of DNA double-strand break repair
DNA双链断裂修复机制及调控
  • 批准号:
    10623591
  • 财政年份:
    2018
  • 资助金额:
    $ 30.04万
  • 项目类别:
Mechanism and regulation of DNA double-strand break repair
DNA双链断裂修复机制及调控
  • 批准号:
    10174946
  • 财政年份:
    2018
  • 资助金额:
    $ 30.04万
  • 项目类别:
Mechanism and regulation of DNA double-strand break repair
DNA双链断裂修复机制及调控
  • 批准号:
    10407594
  • 财政年份:
    2018
  • 资助金额:
    $ 30.04万
  • 项目类别:
CORE B Symington
核心 B 赛明顿
  • 批准号:
    10614994
  • 财政年份:
    2014
  • 资助金额:
    $ 30.04万
  • 项目类别:
Project 2 Symington
项目2赛明顿
  • 批准号:
    10394195
  • 财政年份:
    2014
  • 资助金额:
    $ 30.04万
  • 项目类别:
CORE B Symington
核心 B 赛明顿
  • 批准号:
    10394199
  • 财政年份:
    2014
  • 资助金额:
    $ 30.04万
  • 项目类别:
Project 2 Symington
项目2赛明顿
  • 批准号:
    10614962
  • 财政年份:
    2014
  • 资助金额:
    $ 30.04万
  • 项目类别:
Break-induced replication and genome rearrangements
断裂诱导的复制和基因组重排
  • 批准号:
    8881215
  • 财政年份:
    2010
  • 资助金额:
    $ 30.04万
  • 项目类别:

相似海外基金

Establishment of a new biological assay using Hydra nematocyst deployment
利用水螅刺丝囊部署建立新的生物测定方法
  • 批准号:
    520728-2017
  • 财政年份:
    2017
  • 资助金额:
    $ 30.04万
  • 项目类别:
    University Undergraduate Student Research Awards
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
  • 批准号:
    10368760
  • 财政年份:
    2017
  • 资助金额:
    $ 30.04万
  • 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
  • 批准号:
    10669539
  • 财政年份:
    2017
  • 资助金额:
    $ 30.04万
  • 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
  • 批准号:
    9570142
  • 财政年份:
    2017
  • 资助金额:
    $ 30.04万
  • 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
  • 批准号:
    9915803
  • 财政年份:
    2017
  • 资助金额:
    $ 30.04万
  • 项目类别:
COVID-19 Supplemental work: POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER).
COVID-19 补充工作:用于确定组织特异性吸收电离辐射剂量的护理点生物测定(生物剂量计)。
  • 批准号:
    10259999
  • 财政年份:
    2017
  • 资助金额:
    $ 30.04万
  • 项目类别:
Drug discovery based on a new biological assay system using Yeast knock-out strain collection
基于使用酵母敲除菌株收集的新生物测定系统的药物发现
  • 批准号:
    21580130
  • 财政年份:
    2009
  • 资助金额:
    $ 30.04万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Machine learning for automatic gene annotation using high-throughput biological assay data
使用高通量生物测定数据进行自动基因注释的机器学习
  • 批准号:
    300985-2004
  • 财政年份:
    2005
  • 资助金额:
    $ 30.04万
  • 项目类别:
    Postdoctoral Fellowships
Machine learning for automatic gene annotation using high-throughput biological assay data
使用高通量生物测定数据进行自动基因注释的机器学习
  • 批准号:
    300985-2004
  • 财政年份:
    2004
  • 资助金额:
    $ 30.04万
  • 项目类别:
    Postdoctoral Fellowships
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了